These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7865856)

  • 1. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG).
    Balslev I; Axelsson CK; Zedeler K; Rasmussen BB; Carstensen B; Mouridsen HT
    Breast Cancer Res Treat; 1994; 32(3):281-90. PubMed ID: 7865856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognosis of small primary breast cancers.
    Kollias J; Murphy CA; Elston CW; Ellis IO; Robertson JF; Blamey RW
    Eur J Cancer; 1999 Jun; 35(6):908-12. PubMed ID: 10533470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG).
    Axelsson CK; Mouridsen HT; Zedeler K
    Eur J Cancer; 1992; 28A(8-9):1415-8. PubMed ID: 1515262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of searching for additional prognostic factors in combination with Nottingham Prognostic Index in breast carcinoma patients].
    Jakić-Razumović J; Corić M; Vrbanec D; Babić D; Hlupić L; Belev B
    Lijec Vjesn; 2005; 127(1-2):3-7. PubMed ID: 16145866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lobular invasive breast cancer prognostic factors: About 940 patients].
    Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
    Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying the Nottingham Prognostic Index to a Swedish breast cancer population. South East Swedish Breast Cancer Study Group.
    Sundquist M; Thorstenson S; Brudin L; Nordenskjöld B
    Breast Cancer Res Treat; 1999 Jan; 53(1):1-8. PubMed ID: 10206067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified Nottingham prognostic index for breast cancer patients diagnosed in Denmark 1978-1994.
    Rostgaard K; Mouridsen HT; Vaeth M; Holst H; Olesen KP; Lynge E
    Acta Oncol; 2001; 40(7):838-43. PubMed ID: 11859983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution.
    D'Eredita' G; Giardina C; Martellotta M; Natale T; Ferrarese F
    Eur J Cancer; 2001 Mar; 37(5):591-6. PubMed ID: 11290434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival.
    Grabau D; Jensen MB; Rank F; Blichert-Toft M
    APMIS; 2007 Jul; 115(7):828-37. PubMed ID: 17614850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new perspective on axillary dissection in situations of metastatic sentinel node].
    Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
    Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic correlates of prognosis in lymph node-positive breast carcinomas.
    Clayton F; Hopkins CL
    Cancer; 1993 Mar; 71(5):1780-90. PubMed ID: 8383579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in breast cancer: the value of the Nottingham Prognostic Index for patients treated in a single institution.
    Okugawa H; Yamamoto D; Uemura Y; Sakaida N; Yamada M; Tanaka K; Kamiyama Y
    Surg Today; 2005; 35(11):907-11. PubMed ID: 16249842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
    Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
    J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.
    Shao GL; Wang MC; Fan XL; Zhong L; Ji SF; Sang G; Wang S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034617754024. PubMed ID: 29529946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of nodal ratio on breast cancer recurrence and its potential for incorporation in a new prognostic index.
    Martin FT; O'Fearraigh C; Hanley C; Curran C; Sweeney KJ; Kerin MJ
    Breast J; 2013; 19(4):388-93. PubMed ID: 23721403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.